IRIS
ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 20.223
EU - Europa 18.084
NA - Nord America 13.269
SA - Sud America 5.907
AF - Africa 490
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 23
AN - Antartide 1
Totale 58.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.606
RU - Federazione Russa 10.857
SG - Singapore 8.057
CN - Cina 5.342
BR - Brasile 4.827
HK - Hong Kong 2.697
VN - Vietnam 2.111
IT - Italia 1.698
SE - Svezia 1.573
FR - Francia 1.004
DE - Germania 752
BD - Bangladesh 461
AR - Argentina 402
FI - Finlandia 397
GB - Regno Unito 343
IN - India 327
IE - Irlanda 303
RO - Romania 287
CA - Canada 278
AT - Austria 225
EC - Ecuador 222
MX - Messico 222
ID - Indonesia 188
IQ - Iraq 163
ZA - Sudafrica 149
NL - Olanda 140
JP - Giappone 133
PL - Polonia 119
CO - Colombia 110
ES - Italia 106
TR - Turchia 99
PY - Paraguay 93
MA - Marocco 87
VE - Venezuela 87
PK - Pakistan 86
CL - Cile 73
UA - Ucraina 73
UZ - Uzbekistan 70
SA - Arabia Saudita 61
EG - Egitto 53
KE - Kenya 50
TN - Tunisia 44
LT - Lituania 43
PE - Perù 40
MY - Malesia 36
NP - Nepal 36
PH - Filippine 36
AE - Emirati Arabi Uniti 34
AZ - Azerbaigian 32
DZ - Algeria 32
UY - Uruguay 32
JM - Giamaica 30
AU - Australia 26
JO - Giordania 26
DO - Repubblica Dominicana 24
CH - Svizzera 23
KR - Corea 23
KZ - Kazakistan 23
HN - Honduras 22
IL - Israele 22
OM - Oman 20
IR - Iran 19
BE - Belgio 17
CR - Costa Rica 15
TT - Trinidad e Tobago 15
LB - Libano 14
TH - Thailandia 14
TW - Taiwan 14
AL - Albania 13
BO - Bolivia 13
BH - Bahrain 12
NI - Nicaragua 12
PA - Panama 12
BY - Bielorussia 11
SK - Slovacchia (Repubblica Slovacca) 11
A1 - Anonimo 10
GR - Grecia 10
GT - Guatemala 10
HU - Ungheria 10
ET - Etiopia 9
PS - Palestinian Territory 9
RS - Serbia 9
AO - Angola 8
CI - Costa d'Avorio 8
KG - Kirghizistan 8
NO - Norvegia 8
SY - Repubblica araba siriana 8
XK - ???statistics.table.value.countryCode.XK??? 8
CG - Congo 7
LY - Libia 7
MD - Moldavia 7
SN - Senegal 7
BS - Bahamas 6
CZ - Repubblica Ceca 6
GE - Georgia 6
KW - Kuwait 6
MK - Macedonia 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
KH - Cambogia 5
Totale 57.915
Salva come PNG Salva come JPEG
Città #
Dallas 3.842
Singapore 3.699
Hong Kong 2.671
Moscow 2.359
San Jose 1.669
Ashburn 1.497
Shanghai 1.077
Hefei 986
Lauterbourg 832
Ho Chi Minh City 831
Lawrence 740
Princeton 740
Beijing 539
Hanoi 424
New York 407
São Paulo 356
Milan 346
Helsinki 312
Los Angeles 300
Dublin 298
Nuremberg 234
Santa Clara 190
Rome 187
Rio de Janeiro 152
Orem 132
Boardman 130
Munich 117
Vienna 110
Da Nang 108
Warsaw 103
Belo Horizonte 96
Tokyo 96
Brasília 94
Montreal 82
Frankfurt am Main 80
Curitiba 78
Guayaquil 77
Chennai 76
Mexico City 75
Quito 75
Guangzhou 74
Johannesburg 73
Haiphong 72
London 72
Atlanta 71
Campinas 69
Chicago 69
Council Bluffs 69
Stockholm 69
Toronto 68
Brooklyn 66
Denver 65
Tashkent 65
Baghdad 63
Porto Alegre 63
Houston 61
Biên Hòa 59
Poplar 57
Guarulhos 50
Salvador 50
Boston 48
Phoenix 47
Cesano Boscone 46
Amsterdam 45
Manchester 44
Naples 44
Bologna 43
Lappeenranta 43
San Francisco 41
Mumbai 40
Jakarta 39
Nairobi 39
Turku 39
Buenos Aires 38
Santo André 38
Dhaka 37
Fortaleza 37
Seattle 37
Thái Bình 37
Hải Dương 36
Ribeirão Preto 36
Goiânia 35
Can Tho 34
Shenzhen 34
Buffalo 33
Recife 33
Baku 32
Manaus 32
Tianjin 32
Memphis 31
Washington 31
Brescia 30
Asunción 29
Santiago 29
Sorocaba 28
Cairo 27
Hangzhou 27
New Delhi 27
Nova Iguaçu 27
Riyadh 27
Totale 28.954
Salva come PNG Salva come JPEG
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.406
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 295
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 189
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 185
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 177
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 176
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 170
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 167
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 165
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 159
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 159
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 158
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 156
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 154
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 154
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 150
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 150
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 150
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 149
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 149
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 149
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 147
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 144
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 143
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 143
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 141
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 137
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 130
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 130
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 127
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 125
Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma 120
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 116
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 114
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 113
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 113
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 112
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 111
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 111
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 110
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 110
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 110
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 109
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 108
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 108
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 107
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 107
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 107
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 106
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 105
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 105
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 104
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 104
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 104
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 104
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 103
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 103
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 103
Comparison of CMV reactivation after islet-kidney, pancreas-kidney or kidney alone transplantation in diabetic patients 103
Indocyanine green (ICG)-guided robotic resection for liver adenoma: combined technologies for precision surgery 102
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 102
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 102
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 101
Cornerstones and divergencies in the implementation and use of liver hypertrophy techniques: results from a nationwide survey for the set-up of the prospective registry 100
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 99
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 99
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 98
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 98
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma 97
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 97
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 97
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 96
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 96
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 95
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 95
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies 94
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 94
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 94
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study 94
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres 94
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 94
Assessment of Textbook Outcome in Laparoscopic and Open Liver Surgery 94
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma 93
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 92
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients 92
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis 91
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national register 91
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 91
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma 90
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 90
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial 90
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 90
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments 90
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma 89
Caratterizzazione della omeostasi glucidica in pazienti affetti da diabete mellito di tipo 1 un anno dopo il trapianto di isole pancreatiche 89
Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? 89
Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study 89
Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study 88
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 88
Challenges and Technical Innovations for an Effective Laparoscopic Lymphadenectomy in Liver Malignancies 88
Totale 13.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 351.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 351.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022402 1 0 1 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202640.814 2.611 3.697 4.689 6.017 2.787 1.098 3.288 2.724 10.072 2.380 1.416 35
Totale 59.558